GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (FRA:C6QP) » Definitions » Enterprise Value

C21 Investments (FRA:C6QP) Enterprise Value : €36.40 Mil (As of Jun. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is C21 Investments Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, C21 Investments's Enterprise Value is €36.40 Mil. C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-0.02 Mil. Therefore, C21 Investments's EV-to-EBIT ratio for today is -1,516.63.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, C21 Investments's Enterprise Value is €36.40 Mil. C21 Investments's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 was €2.07 Mil. Therefore, C21 Investments's EV-to-EBITDA ratio for today is 17.59.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, C21 Investments's Enterprise Value is €36.40 Mil. C21 Investments's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 was €26.53 Mil. Therefore, C21 Investments's EV-to-Revenue ratio for today is 1.37.


C21 Investments Enterprise Value Historical Data

The historical data trend for C21 Investments's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Enterprise Value Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of C21 Investments's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Enterprise Value distribution charts can be found below:

* The bar in red indicates where C21 Investments's Enterprise Value falls into.



C21 Investments Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

C21 Investments's Enterprise Value for the fiscal year that ended in Jan. 2023 is calculated as

C21 Investments's Enterprise Value for the quarter that ended in Oct. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (FRA:C6QP) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

C21 Investments's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=36.399/-0.024
=-1,516.63

C21 Investments's current Enterprise Value is €36.40 Mil.
C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

C21 Investments's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=36.399/2.069
=17.59

C21 Investments's current Enterprise Value is €36.40 Mil.
C21 Investments's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.07 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

C21 Investments's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=36.399/26.533
=1.37

C21 Investments's current Enterprise Value is €36.40 Mil.
C21 Investments's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments Enterprise Value Related Terms

Thank you for viewing the detailed overview of C21 Investments's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (FRA:C6QP) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (FRA:C6QP) Headlines

No Headlines